Abstract |
Amino acid substitutions at position 89 or 91 in GyrA of fluoroquinolone-resistant Mycobacterium leprae clinical isolates have been reported. In contrast, those at position 94 in M. tuberculosis, equivalent to position 95 in M. leprae, have been identified most frequently. To verify the possible contribution of amino acid substitutions at position 95 in M. leprae to fluoroquinolone resistance, we conducted an in vitro assay using wild-type and mutant recombinant DNA gyrases. Fluoroquinolone-mediated supercoiling activity inhibition assay and DNA cleavage assay revealed the potent contribution of an amino acid substitution of Asp to Gly or Asn at position 95 to fluoroquinolone resistance. These results suggested the possible future emergence of quinolone-resistant M. leprae isolates with these amino acid substitutions and the usefulness of detecting these mutations for the rapid identification of fluoroquinolone resistance in leprosy.
|
Authors | Kazumasa Yokoyama, Hyun Kim, Tetsu Mukai, Masanori Matsuoka, Chie Nakajima, Yasuhiko Suzuki |
Journal | Antimicrobial agents and chemotherapy
(Antimicrob Agents Chemother)
Vol. 56
Issue 2
Pg. 697-702
(Feb 2012)
ISSN: 1098-6596 [Electronic] United States |
PMID | 22106221
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Fluoroquinolones
- DNA Gyrase
|
Topics |
- Amino Acid Substitution
- Anti-Bacterial Agents
(pharmacology)
- Base Sequence
- DNA Gyrase
(chemistry, genetics)
- Drug Resistance, Bacterial
(genetics)
- Fluoroquinolones
(pharmacology)
- Humans
- Microbial Sensitivity Tests
- Molecular Sequence Data
- Mycobacterium leprae
(drug effects, enzymology, genetics)
|